{"id":"W2269947569","doi":"10.1200/jco.2012.30.15_suppl.5020","title":"Randomized trial of oral cyclophosphamide (C) with or without veliparib (V), an oral poly (ADP-ribose) polymerase (PARP) inhibitor, in patients with recurrent BRCA-positive ovarian, or primary peritoneal or high-grade serous ovarian carcinoma.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Gastroenterology; Internal medicine; Veliparib; PARP inhibitor; Ovarian cancer; Surgery; Randomized controlled trial; Cancer; Poly ADP ribose polymerase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001541862,0.001462223,0.002266183,0.0004311165,0.0004095686,0.001248343,0.0009471019,0.001696572,0.006125175],"category_scores_gemma":[0.001671542,0.000799349,0.001169521,0.000442915,0.001196194,0.0008530542,0.0005128909,0.002894695,0.0009563818],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009126046,"about_ca_system_score_gemma":0.00164406,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001350552,"about_ca_topic_score_gemma":0.002723085,"domain_scores_codex":[0.9993123,0.000385467,0.00003613247,0.0001345463,0.00003451209,0.00009710599],"domain_scores_gemma":[0.9987454,0.0003258473,0.0002590086,0.00009302496,0.00006402884,0.0005126791],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9853438,0.004793616,0.0002924426,0.0001845797,0.0002965675,0.00002570069,0.00001912244,0.0002411288,0.001988709,0.00009915869,0.0004275825,0.006287523],"study_design_scores_gemma":[0.9227431,0.07505497,0.0006433054,0.00001530767,0.0002166132,0.00002721579,0.00001095507,0.0003704679,0.0003317549,0.0001027895,0.0004753161,0.00000818336],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9859365,0.002447458,0.0007794598,0.0007924242,0.000817421,0.005050736,0.001003393,0.0001601814,0.003012365],"genre_scores_gemma":[0.9878156,0.001269457,0.001301618,0.001194272,0.0004937155,0.00373434,0.0007761563,0.0000230575,0.003391737],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006125175,"threshold_uncertainty_score":0.02049077,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06851753896149007,"score_gpt":0.3946114848879246,"score_spread":0.3260939459264345,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}